Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 182.00 | 98.75 | 1.8430 | 2.0535 | |
| SK-BR-3 | Lapatinib | 1 | uM | 8 | 156.25 | 36.27 | 91.00 | 98.75 | 0.9215 | 0.8900 |
| SK-BR-3 | Lapatinib | 10 | uM | 8 | 156.25 | 36.27 | 65.00 | 98.75 | 0.6582 | 0.4974 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 8 | 156.25 | 36.27 | 164.00 | 98.75 | 1.6608 | 1.8412 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 8 | 156.25 | 36.27 | 145.00 | 98.75 | 1.4684 | 1.6091 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 8 | 156.25 | 36.27 | 114.00 | 98.75 | 1.1544 | 1.2090 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 8 | 156.25 | 36.27 | 86.00 | 98.75 | 0.8709 | 0.8175 |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 96.00 | 98.75 | 0.9722 | 0.9613 | |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 51.00 | 98.75 | 0.5165 | 0.2660 | |
| SK-BR-3 | 0 | uM | 8 | 312.50 | 180.33 | 190.00 | 266.00 | 0.7143 | 0.0976 | |
| SK-BR-3 | 0 | uM | 8 | 312.50 | 180.33 | 261.00 | 266.00 | 0.9812 | 0.9335 | |
| SK-BR-3 | 0 | uM | 8 | 312.50 | 180.33 | 322.00 | 266.00 | 1.2105 | 1.8119 | |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 8 | 312.50 | 180.33 | 337.00 | 266.00 | 1.2669 | 2.0497 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 8 | 312.50 | 180.33 | 280.00 | 266.00 | 1.0526 | 1.1916 |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 8 | 312.50 | 180.33 | 409.00 | 266.00 | 1.5376 | 3.3075 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 8 | 312.50 | 180.33 | 220.00 | 266.00 | 0.8271 | 0.4256 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 8 | 312.50 | 180.33 | 378.00 | 266.00 | 1.4211 | 2.7426 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 8 | 312.50 | 180.33 | 283.00 | 266.00 | 1.0639 | 1.2336 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 8 | 312.50 | 180.33 | 384.00 | 266.00 | 1.4436 | 2.8492 |
| SK-BR-3 | 0 | uM | 8 | 312.50 | 180.33 | 393.00 | 266.00 | 1.4774 | 3.0116 | |
| SK-BR-3 | 17-AAG | 0.1 | uM | 8 | 312.50 | 180.33 | 251.00 | 266.00 | 0.9436 | 0.8033 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 8 | 312.50 | 180.33 | 460.00 | 266.00 | 1.7293 | 4.3117 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 8 | 312.50 | 180.33 | 222.00 | 266.00 | 0.8346 | 0.4487 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 8 | 312.50 | 180.33 | 266.00 | 266.00 | 1.0000 | 1.0000 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 8 | 312.50 | 180.33 | 266.00 | 266.00 | 1.0000 | 1.0000 |